ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors.

Wael Jdey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.